Altimmune (ALT) Receivables - Other (2010 - 2017)
Altimmune's Receivables - Other was $798,855 in Q1 2017, down 36.9% from $1.27 million a year earlier but up 14.6% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Receivables - Other (2010 - 2017) Analysis & Trends
At the end of FY2016, Receivables - Other at Altimmune came in at $697,321, down 27.6% from FY2015.
- Receivables - Other shows a five-year compound annual growth rate of -25.4% (FY2011 to FY2016).
- In earlier years, Receivables - Other was $963,345 in FY2015 (+223.9%), $297,431 in FY2014 (-86.5%), $2.2 million in FY2013 (-46.5%) and $4.11 million in FY2012 (+36.2%).
- Quarterly Receivables - Other has moved between $297,431 (Q4 2014) and $4.79 million (Q2 2012) over five years.
- Compared with a year earlier, Receivables - Other was higher in six of the last eight quarters, with growth averaging 57.1%.
- The best year-over-year quarter for Receivables - Other over five years was Q4 2015 (growth of 223.9%); the worst was Q4 2014 (a decline of 86.5%).
- Per Business Quant data, ALT's Receivables - Other in the three quarters before Q1 2017 was $697,321 (Q4 2016), $912,126 (Q3 2016) and $797,913 (Q2 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Altimmune | 575.64 Mn | 575.64 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 798,855.00 |
| Dec 31, 2016 | 697,321.00 |
| Sep 30, 2016 | 912,126.00 |
| Jun 30, 2016 | 797,913.00 |
| Mar 31, 2016 | 1.27 Mn |
| Dec 31, 2015 | 963,345.00 |
| Sep 30, 2015 | 659,663.00 |
| Jun 30, 2015 | 790,185.00 |
| Mar 31, 2015 | 594,259.00 |
| Dec 31, 2014 | 297,431.00 |
| Sep 30, 2014 | 303,667.00 |
| Jun 30, 2014 | 617,396.00 |
| Mar 31, 2014 | 1.65 Mn |
| Dec 31, 2013 | 2.20 Mn |
| Sep 30, 2013 | 1.61 Mn |
| Jun 30, 2013 | 3.69 Mn |
| Mar 31, 2013 | 3.71 Mn |
| Dec 31, 2012 | 4.11 Mn |
| Sep 30, 2012 | 3.68 Mn |
| Jun 30, 2012 | 4.79 Mn |
API Access
Altimmune Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();